Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 123

    1.

    Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

    Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA; International AIDS Society-USA.

    JAMA. 2008 Aug 6;300(5):555-70.PMID: 18677028 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.

    Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM.

    Clin Infect Dis. 2007 Dec 15;45(12):1633-9.PMID: 18190326 [PubMed - indexed for MEDLINE]Related articles

    3.

    Racial differences in end-stage renal disease rates in HIV infection versus diabetes.

    Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM.

    J Am Soc Nephrol. 2007 Nov;18(11):2968-74. Epub 2007 Oct 17.PMID: 17942954 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The impact of HIV on chronic kidney disease outcomes.

    Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM.

    Kidney Int. 2007 Dec;72(11):1380-7. Epub 2007 Sep 5.PMID: 17805235 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects.

    Behler CM, Vittinghoff E, Lin F, Chung RT, Peters MG, Robbins GK, Volberding PA.

    Clin Infect Dis. 2007 May 15;44(10):1375-83. Epub 2007 Apr 12.PMID: 17443478 [PubMed - indexed for MEDLINE]Related articles

    6.

    Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.

    Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA; International AIDS Society--USA Panel.

    Top HIV Med. 2006 Aug-Sep;14(3):827-43.PMID: 17016878 [PubMed]Related articlesFree article

    7.

    Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

    Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA; International AIDS Society-USA panel.

    JAMA. 2006 Aug 16;296(7):827-43.PMID: 16905788 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The New York case: lessons being learned.

    Volberding PA.

    Ann Intern Med. 2005 May 17;142(10):866-8. Epub 2005 Apr 21. No abstract available. PMID: 15845950 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up.

    Michaels MG, Kaufman C, Volberding PA, Gupta P, Switzer WM, Heneine W, Sandstrom P, Kaplan L, Swift P, Damon L, Ildstad ST.

    Transplantation. 2004 Dec 15;78(11):1582-9.PMID: 15591945 [PubMed - indexed for MEDLINE]Related articles

    10.

    Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future.

    Henry DH, Volberding PA, Leitz G.

    J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1221-7. Review.PMID: 15385728 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

    Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding PA.

    JAMA. 2004 Jul 14;292(2):251-65.PMID: 15249575 [PubMed - indexed for MEDLINE]Related articles

    12.

    Anemia in HIV infection: clinical impact and evidence-based management strategies.

    Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M; Anemia in HIV Working Group.

    Clin Infect Dis. 2004 May 15;38(10):1454-63. Epub 2004 Apr 27.PMID: 15156485 [PubMed - indexed for MEDLINE]Related articles

    13.

    Initiating HIV therapy. Timing is critical, controversial.

    Volberding PA.

    Postgrad Med. 2004 Feb;115(2):15-8, 21, 24-6. Review.PMID: 15000057 [PubMed - indexed for MEDLINE]Related articles

    14.

    Human immunodeficiency virus hematology.

    Volberding PA, Baker KR, Levine AM.

    Hematology Am Soc Hematol Educ Program. 2003:294-313. Review.PMID: 14633787 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The pavia consensus statement.

    Volberding PA, Murphy RL, Barbaro G, Barbarini G, Bruno R, Cirelli A, Currie PF, Di Lorenzo G, Fantoni M, Filiced G, Galli M, Grisorio B, Moroni M, Recusani F, Sacchi P, Scevola D, Stein JH, Torre D, Vittecoq D.

    AIDS. 2003 Apr;17 Suppl 1:S170-9. Review. No abstract available. PMID: 12870544 [PubMed - indexed for MEDLINE]Related articles

    16.

    HIV therapy in 2003: consensus and controversy.

    Volberding PA.

    AIDS. 2003 Apr;17 Suppl 1:S4-11. Review.PMID: 12870525 [PubMed - indexed for MEDLINE]Related articles

    17.

    Opportunities and options for treatment research in resource-constrained settings.

    Volberding PA.

    Clin Infect Dis. 2003 Jul 1;37(Suppl 1):S1-3.PMID: 12822126 [PubMed - indexed for MEDLINE]Related articles

    18.

    Does hepatitis C virus infection increase the risk of HIV disease progression?

    Rossi SJ, Volberding PA, Wright TL.

    JAMA. 2002 Jul 10;288(2):241-3. No abstract available. PMID: 12095390 [PubMed - indexed for MEDLINE]Related articles

    19.

    Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

    Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Volberding PA.

    JAMA. 2002 Jul 10;288(2):222-35. Review. Erratum in: JAMA. 2003 Jan-Feb;11(1):32. PMID: 12095387 [PubMed - indexed for MEDLINE]Related articles

    20.

    Who cares for AIDS?

    Volberding PA.

    J Gen Intern Med. 2002 Jan;17(1):82-3. No abstract available. PMID: 11903780 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    HIV expertise: a roundtable.

    Boswell SL, Hecht FM, Powderly WG, Soloway B, Volberding PA.

    AIDS Clin Care. 2001 Sep;13(9):79-81, 84-5. No abstract available. PMID: 11547599 [PubMed - indexed for MEDLINE]Related articles

    22.

    Toward a definition of HIV expertise: a survey of experienced HIV physicians.

    Gerbert B, Moe JC, Saag MS, Benson CA, Jacobsen DM, Feraios A, Hill ME, Bronstone A, Caspers N, Volberding PA.

    AIDS Patient Care STDS. 2001 Jun;15(6):321-30.PMID: 11445014 [PubMed - indexed for MEDLINE]Related articles

    23.

    Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.

    Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA.

    JAMA. 2000 Jan 19;283(3):381-90. Review.PMID: 10647802 [PubMed - indexed for MEDLINE]Related articles

    24.

    Advances in the medical management of patients with HIV-1 infection: an overview.

    Volberding PA.

    AIDS. 1999 Sep;13 Suppl 1:S1-9. Review.PMID: 10546780 [PubMed - indexed for MEDLINE]Related articles

    25.

    Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.

    Deeks SG, Hellmann NS, Grant RM, Parkin NT, Petropoulos CJ, Becker M, Symonds W, Chesney M, Volberding PA.

    J Infect Dis. 1999 Jun;179(6):1375-81.PMID: 10228057 [PubMed - indexed for MEDLINE]Related articles

    26.

    Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel.

    Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA.

    JAMA. 1998 Jul 1;280(1):78-86. Review.PMID: 9660368 [PubMed - indexed for MEDLINE]Related articles

    27.

    Antiretroviral therapy for HIV infection: promises and problems.

    Volberding PA, Deeks SG.

    JAMA. 1998 May 6;279(17):1343-4. Review. No abstract available. PMID: 9582033 [PubMed - indexed for MEDLINE]Related articles

    28.

    HIV/AIDS. Protease inhibitors vindicated.

    Volberding PA.

    Lancet. 1997 Dec 20-27;350 Suppl 3:SIII10. Review. No abstract available. PMID: 9465186 [PubMed - indexed for MEDLINE]Related articles

    29.

    An aggressive approach to HIV antiretroviral therapy.

    Volberding PA.

    Hosp Pract (Minneap). 1998 Jan 15;33(1):81-4, 87-90, 95-6 passim. Review.PMID: 9464233 [PubMed - indexed for MEDLINE]Related articles

    30.

    Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment.

    Ioannidis JP, Bassett R, Hughes MD, Volberding PA, Sacks HS, Lau J.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):22-30.PMID: 9377121 [PubMed - indexed for MEDLINE]Related articles

    31.

    Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel.

    Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA.

    JAMA. 1997 Jun 25;277(24):1962-9.PMID: 9200638 [PubMed - indexed for MEDLINE]Related articles

    32.

    HIV-1 protease inhibitors.

    Deeks SG, Volberding PA.

    AIDS Clin Rev. 1997-1998:145-85. Review. No abstract available. PMID: 9305448 [PubMed - indexed for MEDLINE]Related articles

    33.

    Medicine and HIV. Interview by David Frankel.

    Volberding PA.

    Lancet. 1996 Oct 12;348(9033):1007-8. No abstract available. PMID: 8855865 [PubMed - indexed for MEDLINE]Related articles

    34.

    Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

    Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Sáag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA.

    JAMA. 1996 Jul 10;276(2):146-54. Review.PMID: 8656507 [PubMed - indexed for MEDLINE]Related articles

    35.

    Age as a predictor of progression in HIV infection.

    Volberding PA.

    Lancet. 1996 Jun 8;347(9015):1569-70. No abstract available. PMID: 8667860 [PubMed - indexed for MEDLINE]Related articles

    36.

    HIV viral load markers in clinical practice.

    Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA.

    Nat Med. 1996 Jun;2(6):625-9. Review.PMID: 8640545 [PubMed - indexed for MEDLINE]Related articles

    37.

    Improving the outcomes of care for patients with human immunodeficiency virus infection.

    Volberding PA.

    N Engl J Med. 1996 Mar 14;334(11):729-31. No abstract available. PMID: 8594437 [PubMed - indexed for MEDLINE]Related articles

    38.

    HIV quantification: clinical applications.

    Volberding PA.

    Lancet. 1996 Jan 13;347(8994):71-3. No abstract available. PMID: 8538341 [PubMed - indexed for MEDLINE]Related articles

    39.

    Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma.

    Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD.

    J Clin Pharmacol. 1996 Jan;36(1):55-63.PMID: 8932544 [PubMed - indexed for MEDLINE]Related articles

    40.

    Controversies in initiating anti-retroviral therapy and in the use of combination therapies.

    Volberding PA.

    Adv Exp Med Biol. 1996;394:333-43. Review. No abstract available. PMID: 8815699 [PubMed - indexed for MEDLINE]Related articles

    41.

    A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.

    Volberding PA, Lagakos SW, Grimes JM, Stein DS, Rooney J, Meng TC, Fischl MA, Collier AC, Phair JP, Hirsch MS, et al.

    N Engl J Med. 1995 Aug 17;333(7):401-7.PMID: 7616988 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.

    Kaplan LD, Shiramizu B, Herndier B, Hahn J, Meeker TC, Ng V, Volberding PA, McGrath MS.

    Blood. 1995 Apr 1;85(7):1727-35.PMID: 7535586 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    From the Institute of Medicine.

    Hardy LM, Haynes BF, Volberding PA.

    JAMA. 1994 Aug 10;272(6):423. No abstract available. PMID: 8040965 [PubMed - indexed for MEDLINE]Related articles

    44.

    The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

    Volberding PA, Lagakos SW, Grimes JM, Stein DS, Balfour HH Jr, Reichman RC, Bartlett JA, Hirsch MS, Phair JP, Mitsuyasu RT, et al.

    JAMA. 1994 Aug 10;272(6):437-42.PMID: 7913730 [PubMed - indexed for MEDLINE]Related articles

    45.

    Intermittent therapy.

    Volberding PA.

    J Acquir Immune Defic Syndr. 1994 May;7(5):454-6. No abstract available. PMID: 8158538 [PubMed - indexed for MEDLINE]Related articles

    46.

    Treatment dilemmas in HIV infection.

    Volberding PA.

    Hosp Pract (Off Ed). 1994 Apr 15;29(4):49-54, 59-60.PMID: 7908297 [PubMed - indexed for MEDLINE]Related articles

    47.

    Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.

    Lenderking WR, Gelber RD, Cotton DJ, Cole BF, Goldhirsch A, Volberding PA, Testa MA.

    N Engl J Med. 1994 Mar 17;330(11):738-43.PMID: 7906386 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    HIV, HTLV-I, and CD4+ lymphocytes. Troubles in the relationship.

    Volberding PA.

    JAMA. 1994 Feb 2;271(5):392-3. No abstract available. PMID: 7904318 [PubMed - indexed for MEDLINE]Related articles

    49.

    Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring.

    Hughes MD, Stein DS, Gundacker HM, Valentine FT, Phair JP, Volberding PA.

    J Infect Dis. 1994 Jan;169(1):28-36.PMID: 7903975 [PubMed - indexed for MEDLINE]Related articles

    50.

    Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection.

    Collier AC, Coombs RW, Fischl MA, Skolnik PR, Northfelt D, Boutin P, Hooper CJ, Kaplan LD, Volberding PA, Davis LG, Henrard DR, Weller S, Corey L.

    Ann Intern Med. 1993 Oct 15;119(8):786-93.PMID: 8379600 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...